Compile Data Set for Download or QSAR
Report error Found 133 Enz. Inhib. hit(s) with all data for entry = 1968
TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348827(US9790235, Number I-80)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348828(US9790235, Number I-81)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348833(US9790235, Number I-86)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348821(US9790235, Number I-72)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348822(US9790235, Number I-73)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348819(US9790235, Number I-70)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348820(US9790235, Number I-71)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348825(US9790235, Number I-76)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348826(US9790235, Number I-79)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348823(US9790235, Number I-74)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348824(US9790235, Number I-75)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348846(US9790235, Number I-99)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348849(US9790235, Number I-102)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348850(US9790235, Number I-103)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348848(US9790235, Number I-101)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348838(US9790235, Number I-91)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348859(US9790235, Number I-112)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348866(US9790235, Number I-119)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348863(US9790235, Number I-116)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348864(US9790235, Number I-117)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348852(US9790235, Number I-105)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348858(US9790235, Number I-111)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348745(US9790235, Number I-1)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348878(US9790235, Number I-131)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348748(US9790235, Number I-4)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348750(US9790235, Number I-5)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348746(US9790235, Number I-2)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348840(US9790235, Number I-132 | US9790235, Number I-93)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348747(US9790235, Number I-3)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348869(US9790235, Number I-122)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348870(US9790235, Number I-123)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348873(US9790235, Number I-126)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348871(US9790235, Number I-124)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348872(US9790235, Number I-125)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348765(US9790235, Number I-16)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348766(US9790235, Number I-17)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348762(US9790235, Number I-14)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348763(US9790235, Number I-15)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348769(US9790235, Number I-20)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348770(US9790235, Number I-21)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348767(US9790235, Number I-18)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348768(US9790235, Number I-19)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348754(US9790235, Number I-8)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348755(US9790235, Number I-9)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348751(US9790235, Number I-6)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348753(US9790235, Number I-7)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348757(US9790235, Number I-10)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348759(US9790235, Number I-11)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348781(US9790235, Number I-32)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandPNGBDBM348779(US9790235, Number I-30)
Affinity DataIC50: 100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

Displayed 1 to 50 (of 133 total ) | Next | Last >>
Jump to: